Skip to content

Prognostic model for the determination of clinical outcome of shoulder fractures at 1 year after initial treatment

Prognostic value of different patient, injury or treatment-related factors at the 1-year functional outcome of proximal humerus fractures using the quick-DASH and SPALDI scores

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN57410678
Enrollment
700
Registered
2022-03-22
Start date
2021-03-01
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fractures of the proximal humerus Injury, Occupational Diseases, Poisoning Fracture of upper end of humerus

Interventions

1. Surgical treatment of proximal humeral fractures with either a plate or transosseous sutures 2. Conservative treatment of proximal humerus fractures The medical rec

Sponsors

General University Hospital of Patras
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. At least 18 years old 2. Displaced two-, three-, and four-part fractures of the proximal humerus according to Neer’s classification (displacement >1 cm or angulation >45 degrees) 3. Complete medical records (including full series of pre- and post-operative x-rays)

Exclusion criteria

Exclusion criteria: 1. Nonunion 2. Pathologic fractures 3. Re-fractures 4. Non-displaced fractures 5. Open fractures 6. Concomitant ipsilateral fractures of the upper limb requiring surgery 7. Multiple trauma patients 8. Major nerve or vascular injury 9. Severe dislocation or head splitting component 10. Rotator cuff tear arthropathy or severe rotator cuff insufficiency 11. Severe dementia and/or institutionalization 12. Inability to understand written and spoken guidance in Greek

Design outcomes

Primary

MeasureTime frame
Clinical outcome measured with the Disabilities of Arm, Shoulder and Hand (Quick-DASH score) and the Shoulder Pain and Disability Index (SPANDI score) in 3, 6 and 12 months following the initial treatment

Secondary

MeasureTime frame
There are no secondary outcome measures

Countries

Greece

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026